Cero Therapeutics receives FDA clearance of IND application for CER-1236
CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug ...
manilatimes1d
Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update
Daré will host a conference call and live webcast today, November 14, 2024, at 4:30 p.m. Eastern Time to review financial ...
manilatimes1d
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results
With submission of the updated Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) this week, the Company expects the FDA clearance decision by mid-December, ...
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Submission of New Drug Application for Paltusotine for the Treatment of AcromegalyCompleted Upsized Public Offering of $575M of Common Stock ...